Hmm .. no visuals, but that seemed a very measured, reasonable and fair answer to me. I do agree though that the optics are not good when a Chairperson, who is supposed to lead the BOD and to represent all shareholders in a public company, choses to sell down a large swathe of his or her shares at close to the 12m low. It could imo not unreasonably be perceived as smacking of either desperation, disregard or disrespect, or even, more worryingly, of some kind of price manipulation.. Just a personal perception and concern
- Forums
- ASX - By Stock
- ALK
- Ann: Director Share Sale, Appendix 3Y and ASIC Form 604
Ann: Director Share Sale, Appendix 3Y and ASIC Form 604, page-71
Featured News
Add ALK (ASX) to my watchlist
(20min delay)
|
|||||
Last
49.5¢ |
Change
-0.025(4.81%) |
Mkt cap ! $299.5M |
Open | High | Low | Value | Volume |
50.0¢ | 50.0¢ | 48.0¢ | $541.8K | 1.103M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 267582 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.5¢ | 192599 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 268210 | 0.490 |
7 | 91939 | 0.485 |
7 | 237028 | 0.480 |
4 | 55593 | 0.475 |
6 | 130318 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.495 | 199036 | 20 |
0.500 | 44774 | 11 |
0.505 | 21780 | 4 |
0.510 | 9779 | 3 |
0.515 | 41041 | 3 |
Last trade - 13.59pm 12/11/2024 (20 minute delay) ? |
Featured News
ALK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online